a r t I C l e S Binge alcohol drinking is the most common form of excessive alcohol consumption and contributes to a host of long-term negative health consequences, including alcohol dependence and anxiety disorders [1] [2] [3] [4] [5] . Repeated bouts of binge-induced alcohol intoxication followed by withdrawal are hypothesized to cause aberrant plasticity in brain regions that underlie reward-seeking behavior and stress responsivity, leading to an increased negative affective state that drives increased alcohol consumption 1,6-11 . These effects may be mediated by altered signaling of endogenous stress and anti-stress neuropeptide systems that functionally oppose each other, particularly CRF and NPY 10,12-14 . Central CRF signaling is recruited during binge alcohol drinking, enhances alcohol drinking and anxiety behavior, and is altered in rodent models of alcohol dependence [15] [16] [17] [18] . In contrast, NPY signaling, primarily via Y1R, blunts binge alcohol drinking and reduces anxiety 10,19-21 ; however, the neural locus of these peptidergic effects is unknown. The BNST is a limbic brain structure enriched with CRF and NPY that is a site of integration of stress and reward information 22,23 and may mediate the negative affective state associated with chronic alcohol use. Pharmacological manipulations in the BNST can alter alcohol drinking behaviors 24,25 and chronic alcohol exposure and withdrawal alter the function and plasticity of BNST neurons 26, 27 , but the ability of NPY signaling in the BNST to regulate alcohol drinking has not been evaluated.
RESULTS

Y1R activation in the BNST suppresses binge alcohol drinking
To begin to address these issues, we first examined how pharmacological manipulations of the NPY system in the BNST specific to signaling at its primary receptors, Y1R and NPY-Y2 receptor (Y2R), alter binge alcohol drinking in C57BL/6J mice using the well-described 'drinking in the dark' (DID) model of binge-like alcohol drinking 28 (Fig. 1a and Supplementary Fig. 1a ). We used both agonists and antagonists to assess function associated with receptor activation and endogenous NPY tone, respectively ( Fig. 1 and Supplementary Figs. 1  and 2) . We found that infusion of a Y1R agonist into the BNST, but not adjacent dorsal striatum, reduced binge alcohol consumption (Fig. 1b,c and Supplementary Figs. 1b and 2a) , whereas infusion of a Y1R antagonist into the BNST increased alcohol consumption ( Supplementary Fig. 1c,d) , consistent with our hypothesis that Y1R in the BNST is a neural substrate for NPY's anti-drinking effects. a r t I C l e S (b-f) All statistical comparisons were made using unpaired t tests. Mice that received infusions of LeuPro NPY consumed significantly less ethanol than CON mice during the first 2-h epoch (b; t(12) = 2.59, *P = 0.024), but not the second 2-h epoch (c; P > 0.85) of ethanol DID; LeuPro NPY infusion did not alter measures of anxiety and locomotion in the OF test, including the percentage of time spent in the center (d; P > 0.75) and total distance traveled (e; P > 0.70) or sucrose consumption in sucrose DID (f; P > 0.45). (g,h) Representative traces of mIPSCs (g) and mEPSCs (h) in BNST neurons before and after 10-min bath application of LeuPro NPY (300 nM), and basal frequency and amplitude for neurons used in mPSC experiments. (i) LeuPro NPY increased mIPSC frequency (20.9 ± 6.1%; paired t test baseline versus washout: t(12) = 3.42, P = 0.005; n = 13 neurons, N = 11 mice), but did not alter mIPSC amplitude (P > 0.20). (j) Conversely, LeuPro NPY produced a small decrease in the amplitude of mEPSCs (−6.9 ± 2.3%, paired t test, t(4) = 2.99, P = 0.041; n = 5, N = 3), but did not alter mEPSC frequency (P > 0.60). (k) Inclusion of GDPßS (1 mM; n = 7, N = 4) to block postsynaptic GPCR activity, NEM (50 µM; n = 5, N = 3) to block Gi signaling, PKI (20 µM, n = 6, N = 3) to block PKA signaling and BFA (200 nM; n = 5, N = 4) to prevent receptor trafficking to the membrane all blocked the ability of bath-applied LeuPro NPY to increase mIPSC frequency as it did in the absence of intracellular manipulation shown in control (CON) bar and in i (paired t tests baseline versus washout: P > 0.10), whereas BAPTA (10 µM, t(5) = 3.12, *P = 0.026; n = 6, N = 5) to block calcium and DIP (2 mM, t(5) = 4.76, **P = 0.005; n = 6, N = 3) to block receptor endocytosis did not. LeuPro NPY decreased mIPSC amplitude only when DIP was in the intracellular solution (DIP: paired t test, t(5) = 3.60, *P = 0.016; others: P > 0.05). (l) LeuPro NPY (300 nM) increased the amplitude of the GABA A R-mediated current in response to exogenous GABA (100 µM) applied directly to the postsynaptic neuron by 25.3 ± 7.0% (paired t test baseline versus washout: t(8) = 3.59, P = 0.007; n = 9, N = 7). Inset, representative traces illustrating the effect of LeuPro NPY and complete ablation of the postsynaptic current by the GABA A R blocker GABAzine (20 µM) . All data in b−l are presented as mean ± s.e.m. N represents the number of mice throughout, n the number of neurons.
Notably, the effect of the Y1R antagonist did not emerge until the second half of the binge drinking session, suggesting that endogenous NPY signaling is recruited across the binge drinking session. Neither Y1R modulator in the BNST altered anxiety-like or locomotor behavior in the open field (OF) test or sucrose consumption (Fig. 1d-f and Supplementary Figs. 1e−g and 2b) , suggesting that the behavioral effects of Y1R manipulation were specific to binge alcohol drinking. In contrast, intra-BNST infusion of the Y2R agonist increased alcohol consumption, but decreased sucrose consumption without altering OF behavior ( Supplementary Fig. 1h−l) . Moreover, bilateral infusion of the Y2R antagonist had no measurable effects on behavior ( Supplementary Figs. 1m−q and 2c,d) . These results suggest that manipulation of Y2R in the BNST may alter general rewardseeking and appetitive behaviors rather than binge alcohol drinking as Y1R does.
Mechanism of Y1R-mediated postsynaptic inhibition of BNST neurons
We next investigated the synaptic mechanisms by which this specific Y1R-mediated suppression of alcohol drinking occurs using slice electrophysiology. We found that Y1R activation with the Y1R agonist enhanced the frequency of miniature inhibitory postsynaptic currents Frequency Amplitude npg a r t I C l e S (mIPSCs,) but not miniature excitatory postsynaptic currents (mEPSCs; Fig. 1g-j) . This result suggests a presynaptic locus of Y1R potentially to directly increase GABA release from presynaptic terminals, in direct competition with the previously characterized function of presynaptic Y2R in the BNST of inhibiting presynaptic GABA release 13 . However, Y1R has typically been described as a postsynaptic G i/o -coupled receptor 29, 30 . Thus, to characterize the locus and mechanism of Y1R here in the BNST, we used selective inhibitors of canonical G protein-coupled receptor (GPCR) signaling pathways in the extracellular bath (Supplementary Fig. 3a ) and directly in the postsynaptic neuron ( Fig. 1k) . Disruption of G s /G i signaling with bath application of the PKA inhibitor Rp-adenosine 3′,5′−cyclic monophosphorothioate triethylammonium salt (Rp-cAMPs, 10 µM) blocked the ability of the Y1R agonist [Leu 31 Pro 34 ]-Neuropeptide Y (LeuPro NPY) to increase mIPSC frequency, whereas disruption of the canonical G q signaling pathway with the PLC inhibitor 1-[6-[[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122, 10 µM) did not ( Supplementary Fig. 3a ), suggesting that Y1R is a G i -coupled receptor. However, additional experiments using postsynaptic-specific manipulations of GPCR signaling indicated that Y1R activation increased GABAergic transmission via a postsynaptic, protein kinase A (PKA)-dependent mechanism. Inclusion of the nonhydrolyzable GDP analog guanosine 5′-[β-thio]diphosphate trilithium salt (GDPßS, 1 mM) to block postsynaptic GPCR activity, the vesicle fusion blocker and potent inhibitor of G i signaling N-ethylmaleimide (NEM, 50 µM), and the PKA inhibitor fragment (6−22) amide (PKI, 20 µM) to inhibit PKA signaling in the recording pipette all blocked the ability of bath-applied LeuPro NPY to increase mIPSC frequency, whereas the calcium chelator 1,2-Bis(2-aminophenoxy)ethane-N,N,N' ,N'-tetraacetic acid (BAPTA, 10 µM) did not ( Fig. 1k) . Analysis of basal mIPSC frequency in these experiments revealed that the ability of the Y1R agonist to increase mIPSC frequency was independent of basal frequency ( Supplementary Fig. 3b ).
Because activation of postsynaptic Y1R non-canonically increased mIPSC frequency, rather than amplitude, we evaluated the possible mechanisms of this effect, including alterations in postsynaptic excitability, activation of a retrograde signal to enhance presynaptic GABA release and modulation of postsynaptic GABA receptor (GABAR) function. Analysis of membrane resistance during mIPSC experiments revealed that Y1R activation did not change cell membrane conductance ( Supplementary Fig. 3c ). Furthermore, given that Cs can block K + channels, we also evaluated the effect of LeuPro NPY on mIPSCs using a Cs-based intracellular solution in the recording pipette rather than a K + -based solution. We found a similar effect of the Y1R agonist on mIPSC frequency (20.2 ± 6.4%), suggesting that Y1R activation did not alter the conductance of dendritic K + channels ( Supplementary Fig. 3d ). Next, we examined whether Y1R activates a retrograde messenger or alters postsynaptic GABA receptor function. Y1R activation enhanced IPSCs mediated by superphysiological exogenous application of GABA (100 µM) directly to the postsynaptic neuron, which was ablated by a GABA A R antagonist ( Fig. 1l) , demonstrating that Y1R modulation of postsynaptic GABA responses was present when presynaptic GABA release was occluded and suggesting that the Y1R effect does not occur via activation of a retrograde signal, but via enhancement of postsynaptic GABA A R function. Furthermore, blocking postsynaptic fusion of newly trafficked postsynaptic GABA A Rs to the membrane with the intracellular inhibitor of protein transport to the Golgi apparatus brefeldin A (BFA, 200 nM) prevented the effect of the Y1R agonist on mIPSC frequency, whereas blocking endocytosis of postsynaptic GABA A Rs with dynamin inhibitory peptide (DIP, 2 mM; Fig. 1k ) had no effect. Together, our results suggest that, in the BNST, Y1R is a postsynaptic G i -coupled GPCR that increases the surface expression of postsynaptic GABA A Rs by inhibiting PKA activity, a previously undescribed mechanism of inhibitory plasticity.
Receptor-specific circadian regulation of endogenous NPY signaling Because C57BL/6J mice are nocturnal and binge drink during the dark phase of the light cycle 18, 31 , we next tested the hypothesis that chronic binge alcohol drinking disrupts NPY signaling in the BNST. Although endogenous NPY levels and function have been shown to fluctuate across the light cycle in many brain regions 32 , we found that there were no circadian oscillations in NPY levels or basal GABAergic transmission in the BNST ( Fig. 2a-d) . However, NPY modulation of GABAergic transmission was different across the light cycle ( Fig. 2e,f) . Both the Y1R and Y2R agonists altered mIPSC frequency, but not amplitude, during the light phase of the light cycle, but not the dark phase ( Fig. 2c) . Pre-application of a Y1R antagonist blocked the effect of subsequently applied Y1R agonist (P > 0.90), but not Y2R agonist (t(4) = 3.32, P = 0.029), confirming the receptor specificity of the Y1R-mediated effect (data not shown). Notably, the Y1R antagonist did not modulate GABAergic transmission during either phase of the light cycle, whereas the Y2R antagonist increased mIPSC frequency during the dark phase, but not light phase, of the light cycle ( Fig. 2f) . npg a r t I C l e S Circadian oscillations in Y2R antagonist effects on GABAergic transmission suggest that NPY receptors may be more highly expressed or functionally upregulated during the dark phase, leading to greater endogenous receptor-mediated NPY tone that may occlude the effects of exogenously applied NPY agonists. The inability of the Y1R antagonist to alter GABAergic transmission during the dark phase may be a result of more rapid desensitization of Y1R than Y2R 33 . Furthermore, increased NPY tone during the dark phase may be related to circadian regulation of binge ethanol drinking. Altogether, these results suggest that there is greater NPY receptor expression and receptor-mediated endogenous NPY tone during the dark phase of the cycle, when mice binge drink alcohol.
Chronic binge drinking alters circadian regulation of Y1R function
We tested the hypothesis that circadian regulation in receptor-specific NPY function in the BNST may be important for Y1R modulation of binge alcohol drinking and that the negative behavioral consequences of chronic binge drinking may be mediated by a loss of circadian control of Y1R-mediated NPY signaling in the BNST (Fig. 3) .
We examined BNST neurons 1 d after three cycles of binge drinking in the DID procedure ( Fig. 3a and Supplementary Fig. 4a ) and found that mice that drank ethanol had greater basal spontaneous IPSC frequency, but not amplitude, than those of water-drinking controls (CONs), whereas mIPSC frequency and amplitude were not different between groups (Fig. 3b) . As observed in experiments with naive mice (Fig. 2) , Y1R and Y2R agonists did not modulate GABAergic transmission in BNST neurons of CONs during the dark phase of the light cycle; however, they did in mice that drank ethanol ( Fig. 3c,d ). In addition, Y1R modulation of inhibitory synaptic transmission in mice after three cycles of ethanol drinking could be blocked by intracellular inclusion of a PKA inhibitor ( Fig. 3k ), suggesting an upregulation of the Y1R mechanism characterized above. Consistent with these effects, both Y1R and Y2R protein expression, but not NPY expression, were greater in the BNST of mice that drank ethanol than CONs at this time point ( Fig. 3e-g) . Because there was no alteration in the mRNA of NPY, Y1R, or Y2R ( Supplementary Fig. 4b−d) , this increase in receptor protein expression and function following chronic binge alcohol drinking is likely translation dependent. Notably, NPY protein expression was decreased immediately following the last binge ethanol session of either one or three cycles of ethanol DID compared with CONs ( Fig. 3h) , suggesting that the endogenous NPY system is acutely recruited during each binge ethanol drinking session. To determine whether increased Y1R function following three-cycle DID was merely an acute response to this NPY recruitment and depletion that occurs during each binge ethanol drinking session or whether it requires repeated cycles of binge drinking and withdrawal, we also examined Y1R modulation of inhibitory synaptic transmission 1 d after one-cycle DID. We found that Y1R activation with LeuPro NPY did not alter GABAergic transmission after a single cycle of DID (Fig. 3k) as it did after three cycles, suggesting that the upregulation of Y1R function may be an adaptive response that develops across repeated cycles of binge drinking to compensate for the allostatic burden imposed on the mice from repeated acute recruitment and depletion of NPY that occurs with each binge drinking episode. Furthermore, the enhancement of Y1R function observed after three cycles of binge drinking persisted up to 10 d following the final binge drinking episode ( Fig. 3k) , suggesting that this represents a long-lasting change in the function of the NPY system. To determine the translational potential of these findings, we also investigated how chronic alcohol drinking in non-human primates alters Y1R signaling in the BNST using a well-established model of voluntary, long-term ethanol self-administration in adult male rhesus macaques 34 (Fig. 3i) .
Consistent with mouse experiments, Y1R activation with LeuPro NPY increased GABAergic transmission in BNST neurons of chronic binge-drinking, but not control, monkeys (Fig. 3j,k) . Together, these data indicate that dysregulation of Y1R-mediated endogenous NPY signaling in the BNST is an enduring effect of chronic alcohol use that develops before physical dependence, but persists during long-term binge alcohol drinking and across mammalian species.
Postsynaptic modulation by Y1R in the BNST is specific to CRF neurons When we examined the effect of Y1R activation on GABAergic transmission in the BNST of naive mice, we noted a considerable amount of variability in the magnitude of the effect across individual neurons, which has also been reported in the basolateral amygdala 29 . Given that CRF has been shown to increase alcohol drinking in mice 16, 35 , the opposite phenotype that we found with Y1R activation in the BNST and both peptides is densely expressed in the BNST 13, 36 , we hypothesized that Y1R activation in the BNST decreases binge alcohol drinking by directly inhibiting CRF neurons. We first evaluated the ability of Y1R activation to alter synaptic function at CRF neuron synapses using slice electrophysiology in the BNST of CRF reporter mice (Fig. 4a,b) . CRF + neurons had greater mIPSC amplitude, but not frequency, than CRF − neurons (Fig. 4c,d) . Y1R activation with bath application of LeuPro NPY greatly increased mIPSC frequency in CRF + neurons by 54.7 ± 19.3%, but did not alter mIPSC frequency in CRF − neurons (−1.3 ± 7.8%; Fig. 4e ), suggesting that the effects of Y1R in the BNST are specific to CRF neurons. Furthermore, LeuPro NPY decreased the amplitude and increased the decay time of mIPSCs in CRF + neurons but not CRF − neurons (Fig. 4f,g) . Analysis of the cumulative probability distribution of mIPSC events confirmed that Y1R activation led to an increase in small-amplitude mIPSCs in CRF + , but not CRF − neurons (Fig. 4h) . Together, results suggest that activation of postsynaptic Y1R on CRF neurons in the BNST results in the insertion of GABA A Rs with longer decay kinetics, such as those with α 2/3 subunits, leading to more small-amplitude IPSCs with longer decay.
Direct in vivo chemogenetic activation of G i signaling in BNST CRF neurons suppresses binge drinking
Our results indicate that G i -coupled Y1Rs may be specifically expressed postsynaptically on CRF neurons in the BNST, where they function to decrease binge alcohol drinking by enhancing synaptic inhibition of CRF neurons (Supplementary Fig. 5a ). We directly tested this hypothesis by evaluating whether in vivo activation of G i signaling in CRF neurons in the BNST decreases binge alcohol consumption. We injected the BNST of CRF (also known as Crh)ires-Cre (CRF-Cre) knock-in mice backcrossed to a C57BL/6J background with either a virus containing a Cre-dependent G i -coupled designer receptor activated by designer drug (G i -DREADD) or a control vector 37 (Fig. 5a,b) . Selective chemogenetic activation of the G i -DREADD with bath application of the designer drug clozapine-Noxide (CNO) during slice electrophysiology recordings hyperpolarized G i -DREADD-expressing CRF-Cre neurons in the BNST, confirming that this manipulation functionally inhibited CRF-Cre neurons (Supplementary Fig. 5b,c) . In vivo systemic administration of CNO before ethanol access on day 4, cycle 3 of DID suppressed binge alcohol consumption in mice treated with G i -DREADD, but not with (Fig. 5c) , recapitulating the effect of Y1R activation in the BNST (Fig. 1b) . Notably, CNO injection before the OF test decreased anxiety-like behavior in G i -DREADD mice, but not in control vector mice (Fig. 5d) , without altering locomotor behavior ( Fig. 5e ), suggesting that alterations in binge alcohol drinking and anxiety by manipulation of G i signaling in CRF neurons were not a result of nonspecific locomotor effects of CNO.
Because in vivo inhibition of PKA via activation of G i signaling in BNST CRF neurons reduced binge drinking and anxiety, we also tested whether stimulation of PKA via activation of G s signaling was sufficient to increase the expression of these behaviors using an identical experimental procedure as for G i signaling (Fig. 5f,g) . CNO administration did not alter binge alcohol drinking or OF behavior in mice with the G s -DREADD or control vector (Fig. 5h-j) . However, when mice received both CNO and intra-BNST infusion of the Y1R agonist LeuPro NPY on a subsequent cycle of binge drinking, activation of the G s -DREADD blocked the ability of the Y1R agonist to suppress binge alcohol drinking (Fig. 5k) . This suggests that stimulation of PKA in BNST CRF neurons via G s activation is sufficient to block the PKA-inhibiting mechanism by which Y1R activation regulates binge drinking. This finding provides further in vivo evidence that the mechanism of Y1R-mediated inhibition of BNST CRF neurons that we characterized using ex vivo electrophysiology is the mechanism by which Y1R suppresses binge alcohol drinking.
DISCUSSION
To the best of our knowledge, our data are the first to provide direct evidence that NPY signaling and CRF neurons in the BNST are involved in the regulation of binge alcohol drinking. Many previous reports have demonstrated that NPY and CRF produce divergent alcohol-drinking phenotypes 20, 35 , and our data suggest that this may be a result of their opposing functional roles in the BNST. Furthermore, the anti-drinking effects of NPY are produced by its direct inhibition of BNST CRF neurons via Y1R, suggesting a specific anatomical and synaptic locus for the interaction between these two peptides. Notably, a role for postsynaptic Y1R-mediated inhibition has also recently been reported for the basolateral amygdala 29 , where it is involved in reducing anxiety. However, we found a previously unknown, non-canonical postsynaptic mechanism by which Y1R activation increased the frequency of postsynaptic inhibitory currents, suggesting that Y1R signaling potentiates postsynaptic GABA A R responses, altering plasticity at inhibitory synapses on CRF neurons in the BNST. Given the extensive literature describing the roles of GABARs and CRF in alcohol drinking and dependence 16, 18, 35, [38] [39] [40] [41] [42] [43] , strict modulation of the function and plasticity of GABARs on CRF neurons in the BNST by Y1R may be particularly important for maintaining homeostasis of CRF neuronal activity. Thus, alterations of normal NPY function, such as those after chronic binge alcohol drinking, may have marked consequences on long-term behavioral outcomes, including continued alcohol use that leads to dependence.
We found that the endogenous NPY system was acutely recruited across each binge alcohol drinking session and that as few as three cycles of binge alcohol drinking in rodents, before the development of alcohol dependence 44 , markedly and chronically altered the NPY system in the BNST for at least 10 d after the last binge episode. We observed the same adaptation of Y1R in the BNST of long-term alcohol-drinking rhesus monkeys, suggesting that this adaptation is a common adaptation across voluntary ethanol administration procedures, states of alcohol dependence and species. This is supported by pharmacological and genetic studies that implicate the regulation of NPY in alcohol dependence 1, 3, 20, 21, 45, 46 . The persistence of this widely observed consequence of binge alcohol drinking suggests that Y1R, or more broadly, inhibition of CRF neuron function, may be an effective pharmacotherapeutic target for the prevention and treatment of alcohol abuse.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METhODS
Subjects. Adult male C57BL/6J mice acquired from Jackson Laboratory were 6 weeks old at beginning of the study. CRF-ires-Cre (CRF-Cre, also termed Crh-ires-Cre) mice were generated using bacterial artificial chromosome (BAC) recombineering techniques as described previously 47 . Briefly, an optimized internal ribosome entry sequence fused with a Cre transgene and FRT-flanked neomycin resistance cassette was targeted three bases after the stop codon of the Crh gene contained in a BAC. The final targeting construct contained approximately 4 kb of flanking sequence on either side of the Cre cassette. Following electroporation into embryonic stem cells, positive clones were identified by long-range PCR and confirmed by Southern blotting. Appropriately targeted embryonic stem cells were injected into blastocysts and chimeric animals were generated by the Beth Israel Deaconess Transgenic core. Germline transmission of the targeted transgene was confirmed by PCR of tail DNA using the following primer sequences: CRFstopF2, GATCTCACCTTCCACCTTCTG; CRHstopR2, CAAAGGTTTCCTCCTTGGGG; iresR2, CACACCGGCCTTATTCCAAGC. After confirming germline transmission, the CRF-Cre mice were crossed to a Rosa26-Flpe deleter mouse (JAX stock 003946) to delete the Frt-flanked neo cassette. Deletion of the neo cassette was confirmed by PCR. CRF-Cre mice were backcrossed onto a C57BL/6J strain to maintain consistency with experiments performed in wild-type mice. For some electrophysiology experiments, CRF-Cre mice were crossed with floxed Ai3 (CAG-Floxed EYFP) or floxed Ai9 (CAG-Floxed tdTomato) mice acquired from Jackson Laboratory to allow a priori identification of CRF neurons with fluorescent proteins.
Mice used for signaling and reverse light cycle studies were group housed and mice in drinking experiments were singly housed in colony rooms with 12:12-h light-dark cycle with lights on at 7 a.m. or 7 p.m. Mice had ad libitum access to rodent chow and water. All procedures were approved by the Institutional Animal Care and Use Committee of the University of North Carolina at Chapel Hill and performed in accordance with the US National Institutes of Health guide for the care and use of laboratory animals. dId experiments. We used the 4-d DID procedure ( Fig. 1a and Supplementary  Fig. 1a) , which is a well-established animal model of human binge drinking that generates high ethanol intake and blood ethanol concentrations (≥80 mg dl −1 ) and has been used to characterize neuromodulators of binge-like alcohol consumption 18, 35 . 3 h into the dark cycle, water bottles were replaced with bottles containing a 20% (vol/vol) ethanol solution for 2 h on days 1−3 and 4 h on day 4. For all experiments involving multiple cycles of DID procedures, each cycle was separated by 3 d of abstinence.
First, we examined whether bilateral intra-BNST administration of the following selective NPY receptor modulators could decrease binge alcohol drinking in four distinct experiments using separate cohorts of mice ( Fig. 1a) 0) or in 0.9% (wt/vol) saline, depending on compound administered on cycle 3 challenge) 2 h before ethanol access on the fourth, binge test day of cycle 2 using a 33-gauge micro-injection needle (Hamilton Company) at a rate of 100 nl min −1 . The micro-injection needle was left in place for 1 min post-infusion to allow for adequate diffusion of the drug away from the injector tip. On day 4, cycle 3, mice received intra-BNST infusions of LeuPro NPY or sH 2 0 vehicle (experiment 1), BIBP 3226 or sH 2 0 vehicle (experiment 2), NPY 13-36 or saline vehicle (experiment 3), and BIIE 0246 or sH 2 0 vehicle (experiment 4). Placement into the drug or control group was determined in a pseudo-random fashion so that the two groups had similar means and s.e.m. for baseline ethanol drinking. 10 d after DID, mice in the cohort received the opposite infusion solution before the OF test. 10 d later, mice underwent a cycle of DID with 10% (wt/vol) sucrose instead of ethanol, and they were randomly assigned within the cohort to receive drug or vehicle. Experiments were replicated for LeuPro NPY and BIIE 0246 after two-cycle DID in separate cohorts of mice ( Supplementary Fig. 2) .
Experiments to examine the effect of direct in vivo activation of G i or G s signaling in BNST CRF neurons were conducted similarly (Fig. 5a,f) but used both male and female CRF-Cre mice. Because effects were always present in either both or neither sex, and no differences were observed between sexes, mice were combined for all data presented. After one cycle of DID, CRF-Cre mice received intra-BNST (with respect to Bregma − AP: +0.3 mm, ML: ±1.1 mm, DV: −4.35 mm) microinjections of a virus containing a Cre-dependent G i -coupled designer receptor activated by designer drug (G i -DREADD), AAV8-hSyn-DIO-hM4D-mCherry, or a control vector, AAV8-hSyn-DIO-mCherry, under an anesthetic cocktail of ketamine (100 mg per kg) and xylazine (10 mg per kg). Virus was infused at a rate of 100 nl min −1 for 5 min (400−500 nl total volume each side), and microinjection needles were left in place for 10 min post-infusion. After ~10 d of recovery, mice underwent a second cycle of DID with NaCl (saline) injections (0.9% (vol/vol), intraperitoneal on days 1−3, plus 0.5% (vol/vol) DMSO on day 4) administered 40 min before ethanol access each day. On the next cycle of DID, mice were administered CNO (3 mg per kg, intraperitoneal on day 4), the selective DREADD agonist, instead of vehicle, before ethanol access on the fourth day. Thus, CNO was not delivered until the DREADD virus had been in the BNST for at least 3 weeks to allow for maximal transduction of the viral vector and incorporation and expression of the DREADD receptors 37 . 2 weeks later, mice were given CNO (3 mg per kg, intraperitoneal) immediately before an OF test. Because CNO activation of the DREADD requires approximately 40 min, the first 40 min of OF was used as a baseline to compare to behavior during the activated DREADD. A similar experiment was carried out for examination of G s signaling in BNST CRF neurons using a G s -coupled DREADD virus (AAV8-hSyn-DIO-rM3D-mCherry; G s -DREADD) or control mCherry vector. Mice in the G s -DREADD experiment were subsequently bilaterally cannulated in the BNST and then they underwent an additional cycle of ethanol DID. On the binge test day, mice received CNO (3 mg per kg, intraperitoneal) 180 min before ethanol access, LeuPro NPY (99 pmol per 200 nl per side, inta-BNST) 140 min before ethanol access, and a CNO booster (3 mg per kg, intraperitoneal) 40 min before ethanol access. For in vivo pharmacology and DREADD experiments described above, mice were killed following the last behavior and cannulae and virus injection placements were histologically verified (shown for DREADDs in Fig. 5b,g) . Only mice with bilateral hits were included in data analysis, leading to exclusion of 0-4 mice per group across all experiments, except for the G s -DREADD + LeuPro NPY experiment in which mice that had unilateral cannulae hits were included (n = 2 per group).
To examine the effects of binge alcohol drinking on the NPY system in the BNST, mice underwent one or three cycles of DID and were then killed immediately, 1 or 10 d after the last binge session for electrophysiology, immunohistochemistry or RT-PCR. Mice consumed 6.4−7.2 g per kg on the binge ethanol test day across the three cycles, with corresponding high blood ethanol concentrations (BECs) of 162 mg dl −1 immediately following the cycle 3 binge session (Supplementary Fig. 4a ). This three-cycle DID procedure has been shown to increase alcohol preference in a two-bottle choice procedure without inducing alcohol dependence 44 ethanol self-administration in rhesus monkeys. We used schedule-induced polydipsia to induce voluntary, long-term ethanol self-administration in adult male rhesus monkeys (Macaca mulatta), as previously described 34, 48 . Briefly, monkeys were individually housed in stainless steel cages that allowed for visual, auditory and olfactory sensory contact with each other in a colony room with 12:12-h light-dark cycle with lights on at 7 a.m. Monkeys were trained to use operant panels in their cages that supplied all food, water and ethanol, and all panel data were recorded with a National Instruments interface. Then monkeys were trained daily to use the panel and induced to drink 0.0, 0.5, 1.0 and 1.5 g per kg ethanol (4%) in 30 d epochs. Monkeys were subsequently allowed to voluntarily administer 4% ethanol and water ad libitum for 22 h per d, 7 d per week for 12 calendar months before necropsy (at 5.5−8 years old). Daily average ethanol intake across monkeys ranged from 1.7-2.8 g per kg.
Reverse light cycle signaling experiments.
To examine circadian oscillations in NPY signaling in the BNST, C57BL/6J mice were killed approximately 3 h after lights on or lights off in the colony room, and their brains were harvested npg for electrophysiology or immunohistochemistry experiments. This timing was consistent with all other experiments performed in the current study and with characterized timing of circadian fluctuations in NPY signaling in the hypothalamus 32 . Group assignment was random.
Slice electrophysiology.
We performed whole-cell voltage-clamp electrophysiological recordings in BNST neurons from acutely-prepared coronal brain slices of C57BL/6J mice, CRF-Cre reporter mice and rhesus monkeys as previously described 36 to examine the effects of NPY modulators on synaptic transmission in the BNST, with experimenters blind to experimental condition. Mice were decapitated under isoflurane anesthesia, and their brains were rapidly removed and placed in ice-cold sucrose-artificial cerebrospinal fluid (aCSF) containing (in mM) 194 sucrose, 20 NaCl, 4.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 1.2 NaH 2 PO 4 , 10.0 glucose, and 26.0 NaHCO 3 saturated with 95% O 2 /5% CO 2 . Coronal slices 300 µm in thickness containing the dorsal BNST (Bregma 0.26−0.02 mm) were sectioned on a Leica VT1200 vibratome and stored in a holding chamber of 28−30 °C, oxygenated ACSF containing (in mM) 124 NaCl, 4.4 KCl, 2 CaCl 2 , 1.2 MgSO 4 , 1 NaH 2 PO 4 , 10.0 glucose and 26.0 NaHCO 3 . Slices were transferred to a submerged recording chamber (Warner Instruments), where they were perfused with heated, oxygenated aCSF at a rate of approximately 2 ml min −1 and allowed to equilibrate for 30 min before electrophysiological recordings. For recordings in CRF × Ai3 mice, CRF-Cre-positive neurons were excited by a 490-nm LED and visualized under a 40× immersed objective with GFP filter.
Neurons were held at −70 mV across all voltage-clamp recordings. GABA A Rmediated IPSCs were pharmacologically isolated during recordings by adding kynurenic acid (3 mM) to the bath solution to block AMPA and NMDA receptordependent postsynaptic currents. Recording electrodes were filled with (in mM) 70 KCl, 65 potassium gluconate, 5 NaCl, 10 HEPES, 2 QX-314, 0.6 EGTA, 4 Na-ATP, 0.4 Na-GTP, pH 7.25, 290−295 mOsmol. Glutamatergic EPSCs were isolated by adding picrotoxin (25 µM) to the bath solution to block GABA A R-mediated currents. Recording electrodes were filled with (in mM) 117 gluconic acid, 20 HEPES, 0.4 EGTA, 5 TEA, 2 MgCl2, 2 QX-314, 4 Na-ATP, 0.4 Na-GTP, pH 7.3, 290−295 mOsmol. mIPSCs and mEPSCs were isolated by including tetrodotoxin (500 nM) in the bath solution. For experiments examining the effects of LeuPro NPY on exogenously applied GABA, kynurenic acid (3 mM) was included in the extracellular solution and delivery of GABA (100 µM) was directly administered to the synapse with a Picospritzer. Experiments to functionally confirm DREADDs were performed in currentclamp configuration using a potassium gluconate-based intracellular solution containing (in mM) 135 potassium gluconate, 5 NaCl, 2 MgCl 2 , 10 HEPES, 0.6 EGTA, 4 Na-ATP and 0.4 Na-GTP. Signals were acquired via a Multiclamp 700B amplifier and analyzed using Clampfit 10.3 software (Molecular Devices). Bath-applied drugs were diluted in bath aCSF from stocked frozen aliquots, and intracellular drugs were diluted to working concentrations directly in the intracellular recording solution. Cells were allowed to equilibrate to the recording pipette and intracellular solution for at least 30 min before recordings began. Input resistance and access resistance were continuously monitored during all experiments, and those in which changes in access resistance were greater than 20% were not included in the data analysis.
drugs and viral vectors. The following drugs used in microinfusion and electrophysiology experiments were obtained from Tocris/R&D Biosystems: LeuPro NPY, NPY 13-36, BIIE 0246, BIBP 3226 trifluoroacetate, U73122, guanosine 5′-[β-thio]diphosphate trilithium salt (GDPßS), PKA inhibitor fragment (6−22) amide (PKI), BAPTA and DIP. The following drugs were obtained from Abcam (formerly Ascent): NPY 13-36, SR95531 (GABAzine), kynurenic acid sodium salt, picrotoxin, tetrodotoxin citrate and GABA. The following drugs were obtained from Sigma-Aldrich: Rp-cAMPs, Protein kinase A catalytic subunit from bovine heart (cPKA) and lidocaine N-ethyl bromide. N-Ethylmaleimide (NEM) was obtained from Fisher Scientific, and Brefeldin A was purchased from Cell Signaling Technology. The viral vectors AAV8-hSyn-DIO-hM4D(G i )-mCherry (G i -DREADD), AAV8-hSyn-DIO-rM4D(G s )-mCherry (G s -DREADD) and AAV8-hSyn-DIO-mCherry (control vector), which have been described elsewhere 37 , were obtained from the University of North Carolina Viral Vector Core. CNO was kindly given to us by B. Roth (UNC School of Medicine).
Rt-PcR.
We examined the expression of NPY, Y1R and Y2R mRNA 1 d after the last binge ethanol drinking session using RT-PCR, with experimenters blind to experimental condition of the subjects, which were randomly assigned. Mice were anesthetized with isoflurane and decapitated. Brains were rapidly excised using ice-cold sterilized tools and immersed in ice-cold sterile RNase-free water. Brains were rapidly blocked into 1 mm coronal sections and frozen over dry ice. Bilateral punches of the BNST 1 mm in diameter were taken for each mouse and combined to provide one sample per mouse. Samples were stored at −20 °C in RNAlater RNA stabilization reagent (Qiagen) until being processed by the UNC Genomics core. Cycle threshold (CT, the number of cycles required for the fluorescent signal to cross a set threshold) was determined for the reference gene, Actb, and the target gene. Relative expression (RE) for each target gene was calculated from the following equation and then averaged across samples within each group: RE = 2 −(Ct target gene − Ct reference gene) .
Immunohistochemistry. Mice were anesthetized with Avertin and then perfused intracardially with 0.01 M phosphate buffer saline (PBS) followed by 4% (wt/vol) paraformaldehyde (PFA) in PBS. Brains were extracted and post-fixed for 24 h in 4% PFA, then rinsed twice with PBS and put in 30% (wt/vol) sucrose until saturated. Brains were hemisected and coronal slices 45 µm in thickness containing the BNST were prepared using a Leica VT1200 vibratome (Leica Microsystems) for immunohistochemistry for NPY, Y1R and Y2R. Specificity of all three antibodies have previously been established: the NPY antibody was verified with colocalization of GFP and NPY (>95%) in NPY-sappphire-GFP transgenic mice 49 , and the Y1R 30 and Y2R 50 antibodies have been shown to not react in knockout mice. All immunohistochemistry was performed and quantified by experimenters blind to the experimental conditions of the subjects.
We examined NPY-IR across the light cycle using previously described immunohistochemical methods 36 . All incubations were carried out at room temperature (21−22 °C) and with gentle agitation. Slices were first rinsed in PBS three times for 10 min, incubated in 50% (vol/vol) methanol for 30 min and then 3% (vol/vol) hydrogen peroxide for 5 min to quench endogenous peroxidases, and then rinsed in PBS three more times. Slices were incubated in PBS containing 0.5% (vol/vol) Triton X-100 for 30 min, rinsed with PBS, and incubated in a blocking solution of PBS containing 0.1% Triton X-100 and 10% (vol/vol) normal donkey serum for 60 min. Slices were then directly transferred to blocking solution containing a 1:1,250 concentration of antibody to NPY made in rabbit (Abcam catalog #ab10980) overnight. Slices were rinsed with PBS three times, incubated in a secondary solution containing a 1:200 concentration of antibody to rabbit conjugated to Alexa Fluor 488 made in donkey (Jackson ImmunoResearch Laboratories, catalog #711-545-152) in PBS for 2 h and rinsed in PBS four times. Slices were mounted onto glass slides, allowed to dry, coverslipped with VectaShield (Vector Labs) and stored in the dark at 4 °C.
We also examined protein expression of NPY, Y1R and Y2R after binge alcohol drinking. Immunhistochemical protocols were carried out as previously described 20, 36 . For Y1R-IR, slices were rinsed in PBS, blocked in 10% goat serum and 0.1% Triton X-100 in PBS for 1 h, and then transferred to PBS containing a 1:25,000 concentration of antibody to Y1R made in rabbit for 72 h at 4 °C (antibody 96106 raised against NPY Y1R was provided by CURE/Digestive Disease Research Center, Antibody/RIA Core). After primary incubation, slices were rinsed in PBS and processed with Vectastain ABC Elite Kits (Vector Labs) as per manufacturer's instructions. Sections were visualized by a reaction with 3,3′-diamino-benzidine (DAB, Polysciences, catalog #04001) in a reaction solution containing 0.05% DAB, 0.005% cobalt, 0.007% nickel ammonium sulfate and 0.006% hydrogen peroxide.
For Y2R-IR, slices were incubated in primary solution containing 0.3% (vol/vol) Triton X-100, 0.5% bovine serum albumin and a 1:3,000 concentration of anti-Y2R (Neuromics, catalog #RA14112) for 24 h at 4 °C. Slices were washed in TNT buffer solution containing Tris/HCl, NaCl and Tween20 for 10 min followed by TNB blocking solution containing TNT buffer with 0.5% blocking reagent provided in the TSA kit for 30 min. Slices were washed in TNB solution containing horseradish peroxidase (1:200) for 30 min and rinsed in TNT buffer. Sections were incubated in Cy3 (1:50) in amplification diluents provided in the TSA kit for 10 min and then rinsed in TNT buffer. All slices were mounted onto glass slides, allowed to dry, coverslipped with VectaShield and stored in the dark at 4 °C. 
